Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Gene editing - You Need To See This

How CRISPR Gene Editing Is Revolutionizing Genetic Disease Treatment

Explore how CRISPR gene editing is transforming genetic disease treatment, uncovering breakthroughs, safety advances, and the future possibilities of curing inherited disorders through DNA repair.

Medical Daily

Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high cholesterol

The Independent UK

Gene editing in Indonesia: can new biotechnology solve old agricultural problems?

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting its extraordinary biodiversity.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Gene Editing with CRISPR Technology: Pros, Cons, and the Ethics of Genetic Engineering

CRISPR gene editing offers major medical breakthroughs but raises ethical concerns. Learn its benefits, risks, and societal impact in today's genetic engineering debates.

Medical Daily

Gene Editing Medicine and Personalized Medicine: Breakthroughs Driving Health Innovation Gene Therapy to Transform Care

Explore how gene editing medicine and personalized medicine future breakthroughs are revolutionizing health innovation gene therapy, offering precise, transformative treatments and medical breakthroughs for complex diseases.

Medical Daily

Sam Altman and husband reportedly working to genetically engineer babies from having hereditary disease

Sam Altman and his husband have reportedly invested in a gene-editing startup which aims to eliminate hereditary diseases

The Independent UK

Why Origin Agritech Stock Soared 92% After Hours?

Origin Agritech Ltd. (NASDAQ:SEED) surged 92.3% in after-hours trading on Tuesday.Check out the current price of SEED stock here. Northeast Market Re-Entry Drives Momentum The Beijing-based agricultural technology company held its Northeast Variety Showcase and Technology Seminar in Changchun on September 18-19. According to the company's release, the event drew…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Charlie Kirk Assassinated

Plus: Poland and NATO, gene editing and God, and more...

Reason

Gene that human ancestors lost millions of years ago could help treat gout

Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach has yet to be tested in humans.

LiveScience

'These decisions were completely reckless': Funding cuts to mRNA vaccines will make America more vulnerable to pandemics

mRNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of huge federal funding cuts.

LiveScience

Gene editing technology could be used to save species on the brink of extinction

Earth’s biodiversity is in crisis. An imminent “sixth mass extinction” threatens beloved and important wildlife. It also threatens to reduce the amount of genetic diversity – or variation – within species.

The Conversation

3 Bullish Biotech Stocks With Explosive Growth Trends

These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies

MarketBeat

Gene-edited pigs may soon enter the Canadian market, but questions about their impact remain

The Canadian government is currently considering approving the entry of gene-edited pigs into the food system.

The Conversation

The Future of Cancer Treatment Is Here — And It Starts with the Right Clinical Trial

Cancer research no longer moves slowly; it advances rapidly. Revolutionary discoveries in precision medicine, immunotherapy, and gene editing emerge almost weekly, yet many patients still confront enormous hurdles when they look for cutting‑edge options.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Beyond de-extinction and dire wolves, gene editing can help today’s endangered species

Have you been hearing about the dire wolf lately? Maybe you saw a massive white wolf on the cover of Time magazine or a photo of “Game of Thrones” author George R.R. Martin holding a puppy named after a character from his books.

International Business Times UK

Designer DNA and Ethical Eating: The Brave New World of Biotech Arrives in the UK

Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised treatments and sustainable, ethical meat alternatives.

MarketBeat

CRSPR Stock Could Be Ready to Deliver on Its Massive Promise

CRSPR Therapeutics has ambitious goals for its gene editing technology and may be getting ready to generate the revenue needed to deliver for shareholders

The Independent UK

Baby born with rare life-threatening disorder makes medical history

Researchers hope what they learn from KJ will help other rare disease patients

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Biologist whose innovation saved the life of British teenager wins $3m Breakthrough prize

Prof David Liu is among the winners of 2025’s ‘Oscars of science’, with honours also going to researchers for landmark work on multiple sclerosis, particle physics and ‘skinny jabs’

MarketBeat

2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025

Gene editing is a reality and it has potential to cure hereditary diseases in a single treatment. These 2 stocks are pioneers in the CRISPR/Cas-9 space.

StockNews.com

3 Biotech Stocks with Promising Pipelines to Watch

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene editing and precision medicine transforming healthcare, fundamentally solid biotech stocks such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) are gaining traction. With promising innovations, these stocks could be prime investment opportunities.…

Benzinga

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Benzinga

Intellia's Single-Dose Gene Editing Treatment for ATTR Amyloidosis Gets FDA Fast-Track Approval Boost

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the U.S. Food and Drug Administration (FDA)

The Conversation

RNA editing is the next frontier in gene therapy – here’s what you need to know

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide.

The Guardian - UK

Scientists dismayed as UK ministers clear way for gene editing of crops - but not animals

Advocates urge government to allow ‘precision breeding’ to combat disease, but RSPCA warns of ethical dangers

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Australian Research Council

Food and Drug Administration

Utah Valley University

190 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.